For use on any inflamed or open skin lesions causing moderate to severe pain e.g. fungating wound
Inclusion Criteria | Checked |
In discussion with specialist palliative care team | |
Establish if referral to tissue viability is required or not | |
For the purpose of symptom management (not wound healing) | |
Non-neuropathic, localised pain | |
Opioid naïve patients- only where introduction of systemic opioids would be inappropriate to initiate (or if patient refuses to initiate) | |
Opioid tolerant patients- only where side effects prevent adequate dose escalation of the systemic opioid dose |
Exclusion Criteria | Checked |
Hypersensitivity to morphine injection or water based gel containing local anaesthetic Water based gel containing local anaesthetic composition: please read product leaflet for further information |
|
More than 2 wounds of <10cm diameter | |
Any wound >10cm diameter | |
Age <18 years |
Cautions
• intolerance to systemic side effects of morphine or other opioid derivatives
• severe renal or hepatic impairment- monitor carefully for signs of opioid accumulation & toxicity over time
• heavy bleeding or exuding wounds
Contraindications
• do not use around eye area
• severe impairment of central nervous system
• acute respiratory depression
• topical management of infected wounds (systemic management permitted
Adverse effects
Very few side effects reported but there is a potential for systemic absorption, especially over larger areas, or with higher concentrations. Closely monitor patient for signs of opioid toxicity.
Some patients have complained on pruritus which may be a sign of hypersensitivity towards either morphine or contents of water based gel with local anaesthetic.